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A
Antimicrobial Resistance in India: Now is the
Time for Action
By Dr. Catherine Yuk-ping Lo -  on January 10, 2018
AMR is jeopardizing both human and animal health, concerted coordination
mechanism between the human and animal health sectors is yet to be seen in
India.
ntimicrobial resistance (AMR) refers to the ability
of microbes to become resistant to antimicrobial
drugs, sometimes referred to as “superbugs.” AMR
is not a new phenomenon; Alexander Fleming, the father of
penicillin, had warned in his Nobel Prize speech in 1945, that
bacteria could become resistant to human-invented drugs.
Following Darwin’s idea of evolution, the development of
resistance is in fact a normal evolutionary process for microorganisms, but the selective
pressure exerted by widespread use and misuse, and even abuse of antimicrobial drugs, in
both therapeutic and non-therapeutic ways, accelerates it.
Unregulated and overuse of antibiotics, in both human and animal sides, is the prime reason
for the looming AMR problems. A report entitled “The State of World Antibiotics 2015”
demonstrated that India was the world’s largest consumer of antibiotics for humans (12.9
billion antibiotic pills) in 2010. In comparison, China consumed 10 billion pills and the U.S
6.8 billion. Despite the fact that insufficient access to effective and affordable antibiotics kills
more children in India than does drug resistance, a study reported by Gardiner Harria in
New York Times in 2014 revealed that more than 58,000 infants died in 2013 owing to
bacterial infections that were resistant to most known antibiotics. Antibiotic use as growth
promoters in animal livestock has likewise been rampant in India; it ranks fourth among the
10 nations in terms of antibiotic usage in animal farm. Without prompt government
interventions, antibiotic use in animal livestock will further increase by 82 percent in India
by 2030.
Predicting that India would become the second or the third largest economy by 2050, Lord
Jim O’Neill warned the country will fail to attain this “exciting potential” if it does not scale
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up its effort to tackle the emerging AMR problem. Based on the 2016 report entitled Infection
Prevention, Control and Surveillance: Limiting the Development and Spread of Drug
Resistance, AMR would claim an estimated one million lives in India by 2050, thereby
requiring swift and appropriate responses in the Indian antibiotic regime.
Compared with the immediate challenges of HIV/AIDS, TB, and also malaria,
AMR nevertheless has been a low priority area in most developing as well as
many developed countries.
The early recognition of the AMR as an emerging public health problem can be dated back to
2000 when former World Health Organization (WHO) director-general Dr Gro Harlem
Brundtl and framed AMR as a global crisis. The precedence of bio-terrorism after the
September 11 attacks nonetheless overshadowed the 2000 discourses and the subsequent
release of the WHO Global Strategy for Containment of Antimicrobial Resistance and its
related campaigns in 2001. The early efforts were not successful in calling for urgent global
responses and budget allocation in dealing with the threats posed by AMR.
The discovery of the New Delhi metallo-β-lactamase (NDM-1) gene in India in 2008 and
mobilized colistin resistance (MCR-1) gene in China 2015 has turned the tide on the global
AMR responses. It is believed that the two genes would prompt the world ushering in “the
doomsday scenario of a world without antibiotics,” for NDM-1 causes the bacterium to
produce an enzyme that neutralizes the activities of antibiotics, whereas MCR-1 provides
bacteria with resistance to colistin, a last-line antibiotic. The urgency in dealing with AMR
was then acknowledged when the WHO Member States endorsed a Global Action Plan on
Antimicrobial Resistance (GAP-AMR) in the 68th World Health Assembly (WHA) in May
2015, calling for countries to collaborate to slow down AMR and avoid a post-antibiotic era.
Many countries have prioritized AMR, since then. India is no exception. In line with the
Global AMR Action Plan, a comprehensive AMR National Action Plan 2017-21 has been
formulated in India, identifying six strategic priorities to combat the problem of AMR. The
Ministry of Health & Family Welfare (MoHFW) has likewise identified AMR as one of the top
10 priorities for the Ministry’s collaboration work with the WHO for 2018-2019. The
affirmation of the commitment to deal with AMR problems is further observed when Prime
Minister Shri Narendra Modi pinpointed the Indian AMR problems in his radio programme
“Mann ki Baat.”
Rigorous actions have been taken to address the human usage of antibiotics; the list of
Schedule H has been expanded to restrict the over-the-counter sales of certain third-or-
fourth generation antibiotics in India. Nevertheless, equivalent countermeasures or level of
awareness of AMR was not found on the animal side in the country; farmers can still easily
purchase antibiotics for growth promotion or disease prevention of animal livestock without
prescriptions provided by vets. Taking into account that AMR is jeopardizing both human
and animal health, concerted coordination mechanism between the human and animal
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health sectors (i.e., between the MoHFW and Ministry of Agriculture and Farmers Welfare,
or between medical doctors and vets) is yet to be seen in India.
AMR is happening now; it is not a country specific issue but a global concern that is
threatening global health security. Based on the 2016 World Economic Forum report, to
date, resistant pathogens cause about 700,000 deaths every year. Without taking immediate
and appropriate actions, 10 million people, more than cancer deaths today, will be killed per
year by 2050. Together with effective coordination between human and animal health
sectors, advanced surveillance and reporting systems, a more rigorous use of antibiotics or
alternatives, as well as the development of new chemical and biological protocols to address
infections are thus necessary to mitigate the threat posed by AMR in India and the globe.
Dr. Catherine Yuk-ping Lo
Like this:
Loading...
